99 studies found for:    Open Studies | "Heparin"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  Validating 4Ts for Heparin Induced Thrombocytopenia (HIT)
Condition: Heparin-Induced Thrombocytopenia
Interventions: Other: Scoring 4Ts and Chong scale;   Other: Blood draw
2 Unknown  Generation of Heparin-induced Thrombocytopenia (HIT)-Antibodies Without Prior Heparin Exposure
Conditions: Heparin-Induced Thrombocytopenia;   Thrombosis
Intervention:
3 Recruiting ONE WEEK VERSUS FOUR WEEK HEPARIN PROPHYLAXIS AFTER LAPAROSCOPIC SURGERY FOR COLORECTAL CANCER.
Conditions: The Primary Study Objective is to Assess the Efficacy and;   Safety of Extended 4-week Heparin Prophylaxis Compared to;   Prophylaxis Given for 8±2 Days After Planned Laparoscopic;   Surgery for Colorectal Cancer.;   The Clinical Benefit Will be Evaluated as the Difference in;   the Incidence of VTE or VTE-related Death Occurring Within 30 Days;   From Surgery in the Two Study Groups.
Intervention: Drug: Heparin, Low-Molecular-Weight
4 Recruiting Understanding "Heparin Resistance" in Cardiac Surgery
Conditions: Cardiopulmonary Bypass;   Altered Heparin Response
Interventions: Drug: Heparin;   Drug: ATryn
5 Recruiting Heparin-Induced Thrombocytopenia Score Card Study
Condition: Heparin-Induced Thrombocytopenia
Interventions: Device: ID-PaGIA Heparin/PF4 antibody test;   Procedure: Clinical Prediction Score-HIT Score Card
6 Recruiting Rivaroxaban for Treatment of Patients With Suspected or Confirmed Heparin-Induced Thrombocytopenia
Condition: Heparin-induced Thrombocytopenia
Intervention: Drug: Rivaroxaban
7 Recruiting Argatroban in Critically Ill Patients With Heparin Resistance
Condition: Achievement of a Sufficient Thrombosis Prohpylaxis in Clitically Ill Patients With Heparin Resistance
Intervention: Drug: Argatroban
8 Recruiting Using Intravenous Heparin Versus Standard of Care Subcutaneous Heparin to Prevent Clots After Surgery
Condition: Venous Thrombosis
Interventions: Drug: low dose intravenous heparin (LDIVH);   Drug: Heparin
9 Recruiting DEDICA (Dose of HEparin During Coronary Angioplasty) Trial
Conditions: Stable Angina;   Angina, Unstable;   Non-ST Elevation (NSTEMI) Myocardial Infarction
Interventions: Drug: Low-dose heparin;   Drug: Standard dose heparin
10 Recruiting A Comparison of Dilute Versus Concentrated Heparin for CRRT Anticoagulation
Conditions: Acute Kidney Injury;   Acute Renal Failure;   Heart Failure
Interventions: Drug: Dilute unfractionated heparin;   Drug: Standard concentration unfractionated heparin
11 Unknown  Incidence and Nature of Heparin-induced Skin Lesions in Medical Patients
Condition: Allergy
Intervention:
12 Recruiting Safety and Efficacy of Lean Body Weight-based IV Heparin Dosing in Obese/Morbidly Obese Patients
Conditions: Obesity;   Morbid Obesity;   Venous Thromboembolism;   Atrial Fibrillation;   Angina;   Chest Pain
Intervention: Drug: Lean Body Weight-based heparin dose
13 Recruiting Effect of Low Molecular Weight Heparin: Tinzaparin in Lung Tumours (TILT)
Conditions: Lung Cancer;   Non Small Cell Lung Cancer
Intervention: Drug: Tinzaparin sodium 100 UI/Kg/OD for 12 weeks
14 Unknown  Heparin for Pregnant Women With Thrombophilia
Condition: Pregnancy and Thrombophilia
Intervention: Drug: Nadroparin calcium
15 Recruiting Evaluation of Heparin Rebound in Cardiac Surgery
Condition: Coagulation Delay
Intervention:
16 Recruiting Balloon Aortic Valvuloplasty Performed Without Heparin to Decrease Vascular and Bleeding Complications of the Procedure
Condition: Aortic Stenosis, Non-rheumatic
Interventions: Drug: Heparin;   Drug: NaCl
17 Unknown  Efficacy and Safety of Sodium Heparin in Patients Submitted to Heart Surgery Using Bypass
Condition: Cardiac Surgery
Interventions: Drug: heparin sodium - Bergamo;   Drug: heparin sodium - APP
18 Unknown  Comparing Bivalirudin Versus Heparin/ GP IIB/IIA in Patients Undergoing PCI
Condition: Coronary Artery Disease
Intervention: Procedure: Percutaneous Coronary Intervention (PCI)
19 Not yet recruiting Trial of Nebulized Heparin Versus Placebo for Inhalation Trauma
Conditions: Inhalation Injury;   Burn Injury
Interventions: Drug: unfractionated heparin;   Drug: placebo
20 Recruiting Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy
Conditions: Deep Venous Thrombosis;   Pulmonary Embolism
Interventions: Drug: Low dose nadroparin;   Drug: Intermediate dose nadroparin;   Drug: Low dose enoxaparin;   Drug: Intermediate dose enoxaparin;   Drug: Low dose dalteparin;   Drug: Intermediate dose dalteparin;   Drug: Fixed low dose tinzaparin;   Drug: Intermediate dose tinzaparin

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years